Monitoring and Preemptive Rituximab Therapy for Epstein-Barr Virus Reactivation after Antithymocyte Globulin Containing Nonmyeloablative Conditioning for Umbilical Cord Blood Transplantation-Reference-Cited by-同舟云学术

Monitoring and Preemptive Rituximab Therapy for Epstein-Barr Virus Reactivation after Antithymocyte Globulin Containing Nonmyeloablative Conditioning for Umbilical Cord Blood Transplantation

Published:2010-02 Issue:2 Volume:16 Page:287-291
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Blaes Anne H.,Cao Qing,Wagner John E.,Young Jo-Anne H.,Weisdorf Daniel J.,Brunstein Claudio G.

Funder

National Cancer Institute

Children's Cancer Research Fund

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference26 articles.

1. Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation;Hoshino;Br J Haematol,2001

2. Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load;Hoshino;Bone Marrow Transplant,2000

3. Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease;Gartner;J Clin Microbiol,2002

4. High incidence of PTLD after non-T-cell depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment;Juvonen;Bone Marrow Transplant,2003

5. Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients;Barker;Biol Blood Marrow Transplant,2001

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of pre‐emptive rituximab on EBV DNA levels and prevention of post‐transplant lymphoproliferative disorder in pediatric kidney transplant recipients: A case series from the pediatric nephrology research consortium;Pediatric Transplantation;2024-04-02

2. Viral monitoring in immunocompromised hosts;Molecular Medical Microbiology;2024

3. Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?;Bone Marrow Transplantation;2023-11-25

4. Immune dysregulation as a leading principle for lymphoma development in diverse immunological backgrounds;Immunology Letters;2023-11

5. Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder;Transplantation and Cellular Therapy;2023-01